{"id":"insulin-treatment-for-hyperglycemia","safety":{"commonSideEffects":[{"rate":"variable, dose-dependent","effect":"Hypoglycemia"},{"rate":"common","effect":"Weight gain"},{"rate":"5-10","effect":"Injection site reactions"},{"rate":"rare to uncommon","effect":"Lipodystrophy"}]},"_chembl":{"chemblId":"CHEMBL1201631","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Insulin is a hormone that binds to insulin receptors on muscle, fat, and liver cells, facilitating glucose transport from the bloodstream into these tissues for energy use or storage. This reduces circulating blood glucose levels in hyperglycemic patients. Insulin also suppresses hepatic glucose production and promotes anabolic processes.","oneSentence":"Insulin replaces or supplements the body's own insulin to lower blood glucose by promoting glucose uptake into cells and storage as glycogen.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:33:21.185Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus"},{"name":"Type 2 diabetes mellitus (when oral agents are insufficient)"},{"name":"Hyperglycemia in hospitalized patients"}]},"trialDetails":[{"nctId":"NCT07496619","phase":"NA","title":"Effects of Diabetic Educational Intervention and Dietary Supplements on Blood Glucose, Lipid Profile Levels, Body Mass Index, and Pain Management Among Adult Individuals With Painful Diabetic Peripheral Neuropathy.","status":"COMPLETED","sponsor":"Al-Quds University","startDate":"2022-03-01","conditions":"Pain, Glucose Levels, Low-density Lipoprotein Lipid Composition","enrollment":62},{"nctId":"NCT07329088","phase":"NA","title":"Isoleucine Addition Treatment Effects in a Controlled Diet Study","status":"NOT_YET_RECRUITING","sponsor":"Jean L. Fry","startDate":"2026-05-04","conditions":"Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), Metabolic Syndrome (MetS), Obesity & Overweight","enrollment":40},{"nctId":"NCT04416269","phase":"PHASE4","title":"Oral Anti Diabetic Agents in the Hospital","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2020-08-07","conditions":"Diabetes Mellitus","enrollment":255},{"nctId":"NCT05985135","phase":"NA","title":"Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-06-01","conditions":"Type 1 Diabetes","enrollment":70},{"nctId":"NCT06624956","phase":"PHASE4","title":"Prevention and Treatment of Common Hyperglycemia in Surgery Pilot","status":"COMPLETED","sponsor":"University of Washington","startDate":"2024-09-04","conditions":"Surgery, Non Diabetic Hyperglycemia","enrollment":106},{"nctId":"NCT05660083","phase":"PHASE2","title":"Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2023-01-12","conditions":"HER2-negative Breast Cancer, Metastatic Breast Cancer, Metaplastic Breast Carcinoma","enrollment":36},{"nctId":"NCT07224334","phase":"PHASE1","title":"Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.","status":"RECRUITING","sponsor":"David D'Alessio, M.D.","startDate":"2025-12-30","conditions":"Diabetes (DM)","enrollment":30},{"nctId":"NCT07376850","phase":"NA","title":"Time in rANge vs. Time in nOrmal Glycemia for Better Glycemic Control","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Motol","startDate":"2026-01","conditions":"Diabetes, Diabetes (DM), Diabetes Type 1","enrollment":120},{"nctId":"NCT04341571","phase":"PHASE2","title":"Effect of Probiotics Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Guadalajara","startDate":"2019-10-24","conditions":"PreDiabetes, Impaired Glucose Tolerance, Hyperglycemia","enrollment":30},{"nctId":"NCT06904846","phase":"NA","title":"To Evaluate the Change in Glucose Parameters in Adult Patients With Type 1 or Type 2 Diabetes From Europe Using the iCan o3 CGM System for 60 Days Period","status":"ENROLLING_BY_INVITATION","sponsor":"Sinocare","startDate":"2025-04-23","conditions":"Diabetes Mellitus, Continuous Glucose Monitoring System","enrollment":70},{"nctId":"NCT06445946","phase":"PHASE4","title":"DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-08-01","conditions":"Gestational Diabetes Mellitus, Pregnancy, High Risk","enrollment":1572},{"nctId":"NCT07318740","phase":"NA","title":"Effectiveness of Mobile Application-Supported Education and Counseling in Pregnant Women With Gestational Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Saglik Bilimleri Universitesi","startDate":"2025-08-18","conditions":"Gestational Diabetes Mellitus (GDM)","enrollment":94},{"nctId":"NCT05687500","phase":"PHASE2","title":"Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-05-20","conditions":"Transient; Hypoglycemia, Neonatal, Preterm, Glibenclamide Adverse Reaction","enrollment":35},{"nctId":"NCT07045298","phase":"NA","title":"CGM Use in Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-04","conditions":"Heart Failure, Diabetes Mellitus","enrollment":140},{"nctId":"NCT05090358","phase":"PHASE2","title":"Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-10-08","conditions":"Breast Cancer, Breast Cancer Stage IV, Metastatic Breast Cancer","enrollment":15},{"nctId":"NCT06752928","phase":"NA","title":"A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-05-12","conditions":"Type 1 Diabetes","enrollment":100},{"nctId":"NCT07207694","phase":"NA","title":"WhatsApp-Based Education Program for Stroke Patients","status":"NOT_YET_RECRUITING","sponsor":"Gaziler Physical Medicine and Rehabilitation Education and Research Hospital","startDate":"2025-10-15","conditions":"Type 2 Diabetes Mellitus (T2DM), Stroke","enrollment":84},{"nctId":"NCT07201155","phase":"","title":"The Accuracy of Continuous Glucose Monitoring Systems in Critically Ill Patients","status":"COMPLETED","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2024-05-01","conditions":"Hyperglycemia in Critically Ill Patients","enrollment":55},{"nctId":"NCT04233138","phase":"NA","title":"SUPPORT Online Training Platform for Type 1 Diabetes Self-management Education and Support (SUPPORT)","status":"COMPLETED","sponsor":"McGill University","startDate":"2020-02-05","conditions":"Type 1 Diabetes Mellitus With Hypoglycemia","enrollment":285},{"nctId":"NCT07117240","phase":"PHASE4","title":"Evaluation of the Efficacy and Safety of GLP-1 Receptor Agonist Therapy In Steroid-Induced Diabetes","status":"ENROLLING_BY_INVITATION","sponsor":"Medical University of Warsaw","startDate":"2025-07-10","conditions":"Steroid-Induced Diabetes, Steroid-Induced Hyperglycemia, Diabetes","enrollment":100},{"nctId":"NCT06627517","phase":"NA","title":"Safety and Effectiveness of the Luna System in People With Type 1 Diabetes Mellitus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Luna Diabetes","startDate":"2024-11-22","conditions":"Type 1 Diabetes Mellitus, Sleep Quality","enrollment":120},{"nctId":"NCT05447806","phase":"NA","title":"Diabetes Clinical Decision Support","status":"RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2022-07-15","conditions":"Hyperglycemia, Hyperglycemia Stress, Diabetes","enrollment":15732},{"nctId":"NCT07108426","phase":"NA","title":"Medical Education to Improve Diabetes Care and Outcomes in Hospitalized Patients","status":"COMPLETED","sponsor":"Catholic University of Pelotas","startDate":"2024-08-01","conditions":"Diabete Type 2, Hyperglycemic Therapy, Medical Education","enrollment":50},{"nctId":"NCT04300790","phase":"PHASE2","title":"Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients","status":"COMPLETED","sponsor":"MedSIR","startDate":"2020-10-23","conditions":"Breast Cancer","enrollment":69},{"nctId":"NCT07014735","phase":"NA","title":"Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM","status":"RECRUITING","sponsor":"Richmond Pharmacology Limited","startDate":"2023-04-13","conditions":"Diabetes Type 2, Hyperglycaemia (Diabetic), QT Interval, Variation in","enrollment":24},{"nctId":"NCT06984133","phase":"NA","title":"Structured Education Program and Glycemic Control in Adolescents With Type 1 Diabetes","status":"RECRUITING","sponsor":"Dasman Diabetes Institute","startDate":"2025-05-18","conditions":"Type 1 Diabetes (T1D), Type 1 Diabetes Mellitus (T1DM)","enrollment":128},{"nctId":"NCT05361148","phase":"","title":"Long-term Health After Severe Acute Malnutrition in Children and Adults: the Role of the Pancreas","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2021-01-12","conditions":"Pancreas Atrophy, Diabetes, Malnutrition","enrollment":2305},{"nctId":"NCT06909071","phase":"NA","title":"Hybrid Closed-Loop System in Neurosurgical Perioperative Hyperglycemia: An Open RCT","status":"RECRUITING","sponsor":"Shanxi Bethune Hospital","startDate":"2025-04-15","conditions":"T2DM Patients With Traumatic Brain Injury","enrollment":40},{"nctId":"NCT04414280","phase":"","title":"The Impact of Hybrid Closed-loop Insulin Delivery in Type 1 Diabetes on Glycemic Control and PROMs","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2020-03-12","conditions":"Diabetes Mellitus, Type 1","enrollment":1150},{"nctId":"NCT06671340","phase":"NA","title":"Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Elaine Chow","startDate":"2025-04-02","conditions":"Diabetes Mellitus, Prediabetes / Type 2 Diabetes","enrollment":30},{"nctId":"NCT06765655","phase":"NA","title":"Perioperative Glucose Monitoring and Treatment to Reduce Risk of Surgical Site Infections and Complications","status":"ENROLLING_BY_INVITATION","sponsor":"St. Peter's Hospital, Albany, NY","startDate":"2024-04-09","conditions":"Surgical Site Infections, Stress Hyperglycemia","enrollment":266},{"nctId":"NCT05426096","phase":"NA","title":"Comparison of Intraoperative Best Practice Advisory Reminders to Protocolize Insulin Administration Versus Standard Care in Patients at High Risk of Hyperglycemia","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2022-10-05","conditions":"Diabetes, Hyperglycemia","enrollment":7232},{"nctId":"NCT06613854","phase":"PHASE4","title":"Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes","status":"RECRUITING","sponsor":"University Medical Centre Ljubljana","startDate":"2024-10-01","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":90},{"nctId":"NCT06607224","phase":"NA","title":"Effect of the Use of Continuous Glucose Monitoring Versus Standard Glycemic Control in Hospitalized Patients with Type 2 Diabetes.","status":"COMPLETED","sponsor":"Hospital General Universitario Gregorio Marañon","startDate":"2022-01-10","conditions":"Diabetes Mellitus Type 2, Hospitalization","enrollment":40},{"nctId":"NCT06563687","phase":"NA","title":"Continuous Glucose Monitoring in HIE","status":"RECRUITING","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2024-08-01","conditions":"Hypoxic Ischemic Encephalopathy of Newborn, Hyperglycemia, Hypoglycemia","enrollment":70},{"nctId":"NCT00582036","phase":"NA","title":"Glucose Control In Hematopoetic Stem Cell Transplant","status":"TERMINATED","sponsor":"University of Oklahoma","startDate":"2007-02","conditions":"Hyperglycemia, Hematopoietic Stem Cell Transplantation","enrollment":11},{"nctId":"NCT06007508","phase":"PHASE2","title":"Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis","status":"TERMINATED","sponsor":"HealthPartners Institute","startDate":"2022-05-31","conditions":"DKA","enrollment":8},{"nctId":"NCT05006040","phase":"EARLY_PHASE1","title":"HCL Single Arm Pilot Study in Treatment of Hyperglycemia of Pediatric ALL","status":"TERMINATED","sponsor":"University of Colorado, Denver","startDate":"2022-05-12","conditions":"High Risk Acute Lymphoblastic Leukemia","enrollment":1},{"nctId":"NCT03152890","phase":"PHASE4","title":"Insulin Therapy for Postreperfusion Hyperglycemia","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2017-05-15","conditions":"Hyperglycaemia (Diabetic), Liver Transplantation","enrollment":20},{"nctId":"NCT06208618","phase":"NA","title":"The Impact of Motivational Interviews Conducted Through Tele-Nursing on Diabetes Management","status":"UNKNOWN","sponsor":"Eskisehir Osmangazi University","startDate":"2024-01-15","conditions":"Type 1 Diabetes, Motivational Interviewing","enrollment":96},{"nctId":"NCT06147583","phase":"NA","title":"Assessing Detection Algorithms for Insulin Pump Malfunctions in Type 1 Diabetes","status":"UNKNOWN","sponsor":"University of Padova","startDate":"2023-12","conditions":"Diabetes Mellitus, Type I","enrollment":20},{"nctId":"NCT04818242","phase":"NA","title":"Dexcom Continuous Glucose Monitoring in Long-term Care","status":"COMPLETED","sponsor":"Emory University","startDate":"2021-04-19","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":100},{"nctId":"NCT03877068","phase":"NA","title":"Dexcom G6 Intervention Study","status":"COMPLETED","sponsor":"Emory University","startDate":"2019-06-26","conditions":"Diabetes Mellitus","enrollment":185},{"nctId":"NCT02408120","phase":"PHASE4","title":"Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Emory University","startDate":"2015-10","conditions":"Diabetes Mellitus, Type 2","enrollment":226},{"nctId":"NCT04158921","phase":"NA","title":"Control:Diabetes Pilot Study I","status":"TERMINATED","sponsor":"Brigham and Women's Hospital","startDate":"2019-11-07","conditions":"Insulin Treated Type 2 Diabetes Mellitus, Diabetes Mellitus, Type 1","enrollment":55},{"nctId":"NCT05753657","phase":"EARLY_PHASE1","title":"A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.","status":"RECRUITING","sponsor":"Rambam Health Care Campus","startDate":"2022-12-25","conditions":"Metastatic Breast Cancer, Hyperinsulinism, Hyperglycemia Drug Induced","enrollment":30},{"nctId":"NCT02574156","phase":"PHASE3","title":"Control of Hyperglycemia After Cardiac Surgery: CHyCS Trial","status":"TERMINATED","sponsor":"University of Sao Paulo","startDate":"2017-01-01","conditions":"Hyperglycemia","enrollment":500},{"nctId":"NCT04936633","phase":"NA","title":"Efficacy of FSGM Cloud-based Remote Intervention for Insulin-dEpendent Diabetic Patients (FRIEND)","status":"COMPLETED","sponsor":"Young Shin Song","startDate":"2021-06-30","conditions":"Type 1 Diabetes Mellitus","enrollment":36},{"nctId":"NCT05574023","phase":"NA","title":"Effect of CGM With Predictive Alarm on Hypoglycemia in Young Patients With T1D.","status":"COMPLETED","sponsor":"Azienda Ospedaliera Universitaria Integrata Verona","startDate":"2021-05-10","conditions":"Type 1 Diabetes","enrollment":20},{"nctId":"NCT02272556","phase":"NA","title":"Investigating the Role of the Polyol Pathway in the Central Nervous System","status":"COMPLETED","sponsor":"Yale University","startDate":"2015-02","conditions":"Hyperglycemia","enrollment":138},{"nctId":"NCT04201496","phase":"PHASE1","title":"SGLT2 Inhibitor Adjunctive Therapy to Closed Loop Control in Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Ananda Basu, MD","startDate":"2020-02-24","conditions":"Type 1 Diabetes","enrollment":34},{"nctId":"NCT04335513","phase":"NA","title":"Trial of Early Initiation of CGM-Guided Insulin Therapy in Stage 2 T1D","status":"UNKNOWN","sponsor":"University of Colorado, Denver","startDate":"2020-04-30","conditions":"Type 1 Diabetes, Prediabetic State, Dysglycemia","enrollment":84},{"nctId":"NCT05360147","phase":"PHASE3","title":"Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Third Military Medical University","startDate":"2021-01-20","conditions":"Type 2 Diabetes Mellitus","enrollment":30},{"nctId":"NCT00214916","phase":"PHASE2","title":"Tight Glycemic Control With Intensive Insulin Therapy in PICU","status":"UNKNOWN","sponsor":"Greet Van den Berghe","startDate":"2004-10","conditions":"Critical Illness","enrollment":700},{"nctId":"NCT00591227","phase":"PHASE4","title":"Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol.","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2008-05","conditions":"Type 2 Diabetes Mellitus","enrollment":176},{"nctId":"NCT03076775","phase":"NA","title":"Euglycemia After Antenatal Late Preterm Steroids, the E-ALPS Study","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2017-06-08","conditions":"Pregnancy Preterm, Neonatal Hypoglycemia, Hyperglycemia Drug Induced","enrollment":86},{"nctId":"NCT00882050","phase":"PHASE1, PHASE2","title":"Intravenous Exenatide (Byetta) During Surgery","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2009-03","conditions":"Euglycemia, Hypoglycemia, Hyperglycemia","enrollment":104},{"nctId":"NCT05159843","phase":"NA","title":"Effects of Nursing Diabetes Self-management Education","status":"UNKNOWN","sponsor":"Hospitales Universitarios Virgen del Rocío","startDate":"2022-01-10","conditions":"Diabetes Mellitus, Type 1, Health Behavior","enrollment":176},{"nctId":"NCT04834362","phase":"PHASE4","title":"Insulin for Hyperglycemia in Stroke Trial","status":"COMPLETED","sponsor":"National Institute of Neurosciences and Hospital, Dhaka","startDate":"2021-04-05","conditions":"Hyperglycemia, Stroke, Acute","enrollment":452},{"nctId":"NCT01512654","phase":"NA","title":"Personalized Glucose Predictive and Therapy Advisory System - DIAdvisor 2","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2008-09","conditions":"Diabetes Mellitus, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1","enrollment":60},{"nctId":"NCT05025735","phase":"PHASE2","title":"Alpelisib, Fulvestrant and Dapagliflozin for the Treatment of HR+, HER2 -, PIK3CA Mutant Metastatic Breast Cancer","status":"UNKNOWN","sponsor":"Saint Luke's Health System","startDate":"2021-08-25","conditions":"Metastatic Breast Cancer, HER2-negative Breast Cancer","enrollment":25},{"nctId":"NCT03103009","phase":"PHASE1","title":"Treatment Plan for an Individual Patient With Pasireotide for Hyperinsulinemic Hypoglycemia","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2017-03-22","conditions":"Hyperinsulinemic Hypoglycemia, Post Gastrointestinal Tract Surgery Hypoglycaemia","enrollment":1},{"nctId":"NCT04942756","phase":"NA","title":"GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients.","status":"UNKNOWN","sponsor":"Antea Foundation","startDate":"2021-06-30","conditions":"Palliative Care, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1","enrollment":118},{"nctId":"NCT04758858","phase":"NA","title":"Carbohydrates Under Target for Type 1 Diabetes Management","status":"WITHDRAWN","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2021-03","conditions":"Type 1 Diabetes","enrollment":""},{"nctId":"NCT04542213","phase":"PHASE3","title":"Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19","status":"COMPLETED","sponsor":"Hospital Regional de Alta Especialidad del Bajio","startDate":"2020-08-01","conditions":"Hyperglycemia, Covid19","enrollment":70},{"nctId":"NCT04554615","phase":"NA","title":"Intensive Insulin Therapy as Therapeutic Strategy for Non-diabetic Hyperglycemia After Surgery in ICU","status":"COMPLETED","sponsor":"Tanta University","startDate":"2017-09-14","conditions":"Hyperglycemia, Postoperative Complications, Insulin Resistance","enrollment":86},{"nctId":"NCT04409587","phase":"PHASE4","title":"Basal Insulin Glycemic ControL With DEglugec vs Aspart Via Pump","status":"COMPLETED","sponsor":"Mountain Diabetes and Endocrine Center","startDate":"2018-04-12","conditions":"Type1 Diabetes Mellitus","enrollment":59},{"nctId":"NCT04736225","phase":"NA","title":"Effects of the Insulin Self Titration Education for Type 2 Diabetes Mellitus Patients","status":"COMPLETED","sponsor":"National Taipei University of Nursing and Health Sciences","startDate":"2010-06-01","conditions":"Type2 Diabetes","enrollment":120},{"nctId":"NCT00700154","phase":"NA","title":"Insulin Infusion Diabetes Ulcer","status":"TERMINATED","sponsor":"Karolinska Institutet","startDate":"2011-11","conditions":"Diabetes Mellitus, Insulin Resistance, Hyperglycemia","enrollment":40},{"nctId":"NCT02229227","phase":"PHASE3","title":"Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-11-21","conditions":"Diabetes Mellitus, Type 2","enrollment":814},{"nctId":"NCT04414579","phase":"PHASE4","title":"The Efficacy and Safety of Faster Insulin Aspart (Fiasp®) Compared to Conventional Insulin Aspart (NovoLog®) as Correction Bolus","status":"UNKNOWN","sponsor":"Mountain Diabetes and Endocrine Center","startDate":"2019-03-27","conditions":"Type 1 Diabetes Mellitus","enrollment":45},{"nctId":"NCT03150030","phase":"","title":"Hypoglycaemia and Cardiac Arrhythmias in Type 2 Diabetes","status":"COMPLETED","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2017-02-01","conditions":"Diabetes Mellitus, Type 2, Arrhythmia, Cardiac","enrollment":42},{"nctId":"NCT03682237","phase":"NA","title":"Optimizing Metabolic Control in Type 1 Diabetes - The Automatic Bolus Calculator Flash Study","status":"COMPLETED","sponsor":"Steno Diabetes Center Copenhagen","startDate":"2018-10-01","conditions":"Diabetes Mellitus, Type 1","enrollment":184},{"nctId":"NCT00700362","phase":"","title":"Insulin Infusion and Infectious Diabetic Foot Ulcers (IIIFU)","status":"WITHDRAWN","sponsor":"Karolinska Institutet","startDate":"2011-12","conditions":"Diabetes Mellitus, Insulin Resistance, Hyperglycemia","enrollment":""},{"nctId":"NCT03511521","phase":"PHASE4","title":"Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2018-03-27","conditions":"Hyperglycemia Steroid-induced, Insulin Resistance, Diabetes","enrollment":3},{"nctId":"NCT02021903","phase":"NA","title":"Post-prandial Hypotension and Sleepiness in Parkinson's Disease and Other Synucleinopathies","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2012-05","conditions":"Parkinsonian Disorders","enrollment":21},{"nctId":"NCT03578991","phase":"NA","title":"Diabetes as an Accelerator of Cognitive Impairment and Alzheimer's Disease","status":"COMPLETED","sponsor":"Parc Sanitari Pere Virgili","startDate":"2019-07-01","conditions":"Patients Aged 65-85 (Both Included), Diagnosed of Mild Cognitive Impairment, Diagnosed of Type 2 Diabetes in Active Treatment (Hypoglycemic Agents) for a Period ≥5 Years","enrollment":54},{"nctId":"NCT00535925","phase":"PHASE4","title":"Nephropathy In Type 2 Diabetes and Cardio-renal Events","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2005-10","conditions":"Diabetic Nephropathy","enrollment":850},{"nctId":"NCT04009603","phase":"NA","title":"Comparison of Probiotics, Metformin & Their Combination Therapy in the Treatment of PCOS","status":"COMPLETED","sponsor":"Ziauddin University","startDate":"2018-12-06","conditions":"Polycystic Ovary Syndrome","enrollment":78},{"nctId":"NCT01804803","phase":"NA","title":"DIgital Assisted MONitoring for DiabeteS - I","status":"COMPLETED","sponsor":"University of Bari","startDate":"2013-09-09","conditions":"Diabetes Mellitus","enrollment":123},{"nctId":"NCT03091712","phase":"NA","title":"Insulin Degludec Titration Using Mobile Insulin Dosing System","status":"COMPLETED","sponsor":"Glooko","startDate":"2017-05-05","conditions":"Type 2 Diabetes Mellitus","enrollment":240},{"nctId":"NCT02556918","phase":"PHASE4","title":"Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery","status":"COMPLETED","sponsor":"Emory University","startDate":"2016-01","conditions":"Hyperglycemia","enrollment":202},{"nctId":"NCT02155855","phase":"NA","title":"Telemedicine for Adolescents With Insulin-dependent Diabetes","status":"COMPLETED","sponsor":"Texas Tech University Health Sciences Center","startDate":"2014-12","conditions":"Type 1 Diabetes","enrollment":40},{"nctId":"NCT02959762","phase":"NA","title":"Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II)","status":"UNKNOWN","sponsor":"Augusta University","startDate":"2016-10","conditions":"Obesity, Insulin Resistance, Obesity in Diabetes","enrollment":30},{"nctId":"NCT02868606","phase":"","title":"Physiologic Insulin Therapy for the Management of Hyperglycemia in the Hospital","status":"COMPLETED","sponsor":"Winthrop University Hospital","startDate":"2015-07","conditions":"Diabetes Mellitus, Type 2, Hyperglycemia","enrollment":40391},{"nctId":"NCT03970668","phase":"","title":"Linagliptin in Post-renal Transplantation","status":"COMPLETED","sponsor":"Universidad de Guanajuato","startDate":"2016-01-01","conditions":"Transplanted Kidney Complication","enrollment":28},{"nctId":"NCT02060383","phase":"PHASE4","title":"Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2014-05-23","conditions":"Cushing's Disease, Acromegaly","enrollment":249},{"nctId":"NCT03895138","phase":"NA","title":"Trial to Investigate the in Silico Optimization of Insulin Treatments","status":"UNKNOWN","sponsor":"University of Virginia","startDate":"2018-03-19","conditions":"Coronary Artery Bypass","enrollment":35},{"nctId":"NCT01683331","phase":"PHASE4","title":"A Clinical Trial to Prevent New Onset Diabetes After Transplantation","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2012-08","conditions":"Prevention of New Onset Diabetes Among Kidney Transplant Patients","enrollment":251},{"nctId":"NCT01894568","phase":"PHASE3","title":"A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Treatment","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2013-07","conditions":"Type 2 Diabetes Mellitus","enrollment":388},{"nctId":"NCT02004366","phase":"PHASE4","title":"Linagliptin Inpatient Trial","status":"COMPLETED","sponsor":"Emory University","startDate":"2014-01","conditions":"Type 2 Diabetes","enrollment":295},{"nctId":"NCT03507829","phase":"PHASE3","title":"Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2012-11-21","conditions":"Hyperglycemia","enrollment":263},{"nctId":"NCT01378117","phase":"PHASE4","title":"Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Emory University","startDate":"2011-08","conditions":"Type 2 Diabetes Mellitus, Hospitalization, Hyperglycemia","enrollment":90},{"nctId":"NCT01187329","phase":"NA","title":"The Effect of the Hyperinsulinemic Normoglycemic Clamp on Myocardial Function and Utilization of Glucose","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2010-10","conditions":"Hyperglycemia, Aortic Valve Replacement, Aortic Stenosis","enrollment":100},{"nctId":"NCT03748251","phase":"NA","title":"Management of Glycemia Following a Pizza Meal","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2018-02-14","conditions":"Diabetes Mellitus, Type 1","enrollment":38},{"nctId":"NCT00394524","phase":"NA","title":"Trial Between a Computer-Guided Insulin Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU","status":"COMPLETED","sponsor":"Emory University","startDate":"2006-06","conditions":"Diabetes or With New Hyperglycemia","enrollment":160},{"nctId":"NCT00979628","phase":"PHASE4","title":"Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)","status":"COMPLETED","sponsor":"Guillermo Umpierrez, MD","startDate":"2010-01","conditions":"Type 2 Diabetes, Hyperglycemia","enrollment":375},{"nctId":"NCT01792830","phase":"PHASE3","title":"Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients","status":"COMPLETED","sponsor":"Emory University","startDate":"2012-10","conditions":"Poor Glycemic Control","enrollment":175},{"nctId":"NCT01755416","phase":"PHASE2","title":"Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2013-01","conditions":"Type 1 Diabetes","enrollment":18},{"nctId":"NCT02741687","phase":"PHASE4","title":"Sitagliptin in Non-Diabetic Patients Undergoing General Surgery","status":"COMPLETED","sponsor":"Emory University","startDate":"2016-06","conditions":"Hyperglycemia","enrollment":80}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Insulin treatment for hyperglycemia","genericName":"Insulin treatment for hyperglycemia","companyName":"University of Michigan","companyId":"university-of-michigan","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Insulin replaces or supplements the body's own insulin to lower blood glucose by promoting glucose uptake into cells and storage as glycogen. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus (when oral agents are insufficient), Hyperglycemia in hospitalized patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}